Funds observational studies in musculoskeletal, rheumatic, and skin diseases with simplified review changes, R01 clinical trials excluded.
Funding for NIAMS Clinical Trial Implementation with simplified review changes; open for UG3/UH3 clinical trials under this Cooperative Agreement.
This grant supports short-term exploratory clinical trials to improve prevention, diagnosis, or treatment of arthritis, musculoskeletal, or skin diseases through early-stage research.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
NIAMS offers R03 small grants to K01/K08/K23/K25 awardees in years 2-4 to boost research capabilities as they transition to independent investigator status; clinical trials are not allowed.